Health Condition 1: J30-J39- Other diseases of upper respiratory tract
Conditions
Interventions
Intervention1: Group A: Trial drug (Amalakyadi Rasayana): The proposed trial drug Amalakyadi Rasayana will be prescribed in doses according to body weight of children (180 to200 mg/kg/day) for 12 week
Sponsors
National Institute of Ayurveda Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: 1.Children aged from 1-10 years of either sex. 2.Children with recurrent respiratory infections.
Exclusion criteria
Exclusion criteria: 1.Subjects suffering from major systemic illness necessitating long term treatment 2.Subjects with evidence of malignancy 3.Subjects with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S.creatinine >1.2mg/dl), uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4.Co-morbidity like TB, UTI and bleeding disorders etc 5.H/o hypersensitivity to any of the trial drug or their ingredients 6.Subjects who have completed participation in any other clinical trial during the past six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To decrease the morbidity status in children with trial drug. Timepoint: 84 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To observe the immune enhancing effect of Amalakyadi RasayanTimepoint: 84 days | — |
Countries
India
Contacts
Public ContactDr Nisha Ojha
National Institute of Ayurveda Jaipur, Rajasthan
Outcome results
None listed